Patents by Inventor Eric Brustad
Eric Brustad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250109428Abstract: In some examples, a hybrid particle for use in capturing a polynucleotide may include a scaffold molecule including a seeding primer and a plurality of first moieties, and a nanoparticle including a plurality of second moieties. The scaffold molecule is coupled to the nanoparticle via interactions between the plurality of first moieties and the plurality of second moieties.Type: ApplicationFiled: September 27, 2024Publication date: April 3, 2025Applicant: Illumina, Inc.Inventors: Olivia Ghazinejad, Fei Shen, Kyle Bentz, Rohit Subramanian, Eric Brustad, Lena Storms, Xiaoyu Ma, Mathieu Lessard-Viger, Jeffrey Brodin
-
Publication number: 20250101505Abstract: In some examples, a dendritic molecule may include a dendritic core; a seeding primer coupled to the dendritic core; and a plurality of dendrons, each of the dendrons comprising an inert, elongated polymer comprising a first end coupled to the dendritic core and a second end coupled to a first functional group, wherein the first functional group is to react with a second functional group to form a covalent bond. In other examples, a dendritic molecule may include a dendritic core; a single-stranded polynucleotide covalently bonded to the dendritic core; and a plurality of dendrons, each of the dendrons comprising an inert, elongated polymer comprising a first end coupled to the dendritic core and a second end.Type: ApplicationFiled: September 24, 2024Publication date: March 27, 2025Applicant: Illumina, Inc.Inventors: Nam Trong Nguyen, Xavier von Hatten, Xiangyuan Yang, Eric Brustad, Will Tovey, Matthew Worsdale, Gianluca Artioli, Teodora Gal
-
Generating nucleic acids with modified bases using recombinant terminal deoxynucleotidyl transferase
Patent number: 12209266Abstract: Disclosed herein include methods of generating a single stranded deoxyribonucleic acid (ssDNA) scaffold comprising nucleotides with modified bases using a recombinant terminal deoxynucleotidyl transferase (TdT). The recombinant TdT can comprise an amino acid sequence that is at least 80% identical to a Bos taurus TdT, or a fragment thereof, and for example comprise one or more amino acid substitution mutations at one or more positions functionally equivalent to Glu191, Lys193, Glu194, Asp242, Lys287, Phe296, Met299, Thr342, and His420 in the Bos taurus TdT.Type: GrantFiled: May 11, 2021Date of Patent: January 28, 2025Assignees: Illumina, Inc., Illumina Singapore Pte. Ltd.Inventors: Saurabh Rajendra Nirantar, Sergio Peisajovich, Eric Brustad -
Publication number: 20240279733Abstract: The present disclosure is directed to decoupling library capture (template seeding) from cluster generation to optimise both processes. This is achieved by introducing orthogonality between the seeding and clustering primer.Type: ApplicationFiled: December 15, 2022Publication date: August 22, 2024Applicant: Illumina, Inc.Inventors: Fei Shen, Mathieu Lessard-Viger, Eric Brustad, Allison Meade, Esteban Armijo, Michael Howard, Jeffrey Fisher, Jonathan Boutell, Ramon Saracho, Olivia Ghazinejad, Seth McDonald, Lena Storms, Jeffrey Brodin
-
Publication number: 20240271185Abstract: Disclosed herein include methods, compositions, reaction mixtures, kits and systems for identification of methylated cytosines in nucleic acids using a bisulfite-free, one-step chemoenzymatic modification of methylated cytosines.Type: ApplicationFiled: August 16, 2022Publication date: August 15, 2024Inventors: Colin Brown, Xiaohai Liu, Xiaolin Wu, Eric Brustad, Sarah E. Shultzaberger
-
Publication number: 20240182881Abstract: The present disclosure is concerned with proteins, methods, compositions, and kits for mapping of methylation status of nucleic acids, including 5-methylcytosine and 5-hydroxymethyl cytosine (5 hmC). In one embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to thymidine or modified thymidine analogues. In another embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to uracil or thymidine and selectively do not act on other certain modified cytosines of target nucleic acids. Also provided are compositions and kits that include one or more of the proteins and methods for using one or more of the proteins.Type: ApplicationFiled: December 13, 2023Publication date: June 6, 2024Applicant: ILLUMINA, INC.Inventors: Dewei Joel Toh, Leslie Yee Ming Beh, Shu Ting Tan, Anna Traczyk, Saurabh Nirantar, Eric Brustad, Hamed Tabatabaei Ghomi, Zahra Fahmi, Lekha Ravichandraprabhu, Colin Brown, Kayla Busby, Stephen Gross, Rebekah Karadeema, Huy Lam, Pascale Mathonet, Sarah E. Shultzaberger, Kathleen Tzeng, Allison Kathleen Yunghans
-
Publication number: 20240117426Abstract: In some examples, novel nanogel particles are described having dual functionality, temperature responsiveness and pH responsiveness. For nucleic acid sequencing, amplification primers are grafted to nanogel particles to form primer-grafted nanogel particles, and the primer-grafted nanogel particles are captured onto surfaces within a flow cell. Within flow cells such as used in SBS nucleic acid sequencing, each primer-grafted nanogel particle functions as a nano-well in the flow cell, thus eliminating the need for nano-wells in some examples.Type: ApplicationFiled: September 18, 2023Publication date: April 11, 2024Applicants: Illumina, Inc., Illumina Cambridge LimitedInventors: Nam Nguyen, Xavier von Hatten, Will Tovey, Andrew Brown, Wayne George, Eric Brustad, Gianluca Artioli
-
Publication number: 20230348973Abstract: The present disclosure is generally directed to strategies for template capture and amplification during sequencing. In some examples, a solid support is used for template capture and amplification.Type: ApplicationFiled: March 30, 2023Publication date: November 2, 2023Applicant: ILLUMINA CAMBRIDGE LIMITEDInventors: Xiaoyu Ma, Mathieu Lessard-Viger, Eric Brustad, Jeffrey Fisher, Jonathan Boutell, Weihua Chang
-
Publication number: 20220290234Abstract: Examples provided herein are related to detecting methylcytosine and its derivatives using S-adenosyl-L-methionine analogs (xSAMs). Compositions and methods for performing such detection are disclosed. A target polynucleotide may include cytosine (C) and methylcytosine (mC). The method may include (a) protecting the C in the target polynucleotide from deamination; and (b) after step (a), deaminating the mC in the target polynucleotide to form thymine (T). Protecting the C from deamination may include adding a protective group to the 5 position of the C, e.g., using a methyltransferase enzyme that adds the first protective group from an xSAM.Type: ApplicationFiled: March 14, 2022Publication date: September 15, 2022Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITEDInventors: Sarah Shultzaberger, Xiaolin Wu, Eric Brustad, Niall Gormley
-
GENERATING NUCLEIC ACIDS WITH MODIFIED BASES USING RECOMBINANT TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE
Publication number: 20210355518Abstract: Disclosed herein include methods of generating a single stranded deoxyribonucleic acid (ssDNA) scaffold comprising nucleotides with modified bases using a recombinant terminal deoxynucleotidyl transferase (TdT). The recombinant TdT can comprise an amino acid sequence that is at least 80% identical to a Bos taurus TdT, or a fragment thereof, and for example comprise one or more amino acid substitution mutations at one or more positions functionally equivalent to Glu191, Lys193, Glu194, Asp242, Lys287, Phe296, Met299, Thr342, and His420 in the Bos taurus TdT.Type: ApplicationFiled: May 11, 2021Publication date: November 18, 2021Inventors: Saurabh Rajendra Nirantar, Sergio Peisajovich, Eric Brustad -
Publication number: 20210187470Abstract: Provided is a nanoparticle including a scaffold, a single template site for bonding a template polynucleotide to the scaffold, and a plurality of accessory sites for bonding accessory oligonucleotides to the scaffold, wherein the scaffold is selected from an asymmetrical acrylamide polymer one or a dendrimer including lysyl constitutional repeating units, the single template site for bonding a template polynucleotide to the scaffold is selected from a covalent template bonding site and a noncovalent template bonding site and the plurality of accessory sites for bonding accessory oligonucleotides to the scaffold are selected from covalent accessory oligonucleotide bonding sites and noncovalent accessory oligonucleotide bonding sites. Also provided are methods of using the nanoparticle.Type: ApplicationFiled: December 22, 2020Publication date: June 24, 2021Applicants: LLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.Inventors: Xiangyuan YANG, Wayne N. GEORGE, Pietro GATTI LAFRANCONI, Yin Nah TEO, Andrew A. BROWN, Maria Rogert BACIGALUPO, Eric BRUSTAD, Hassan BOHRA, Clifford WANG
-
Publication number: 20210187469Abstract: Provided is a nanoparticle including a scaffold, a single template site for bonding a template polynucleotide to the scaffold, and a plurality of accessory sites for bonding accessory oligonucleotides to the scaffold, wherein the scaffold is selected from one or more scaffold DNA molecules and one or more scaffold polypeptides, the single template site for bonding a template polynucleotide to the scaffold is selected from a covalent template bonding site and a noncovalent template bonding site and the plurality of accessory sites for bonding accessory oligonucleotides to the scaffold are selected from covalent accessory oligonucleotide bonding sites and noncovalent accessory oligonucleotide bonding sites. Also provided are methods of using the nanoparticle.Type: ApplicationFiled: December 22, 2020Publication date: June 24, 2021Applicants: ILLUMINA, INC., ILLUMINA CAMBRIDGE LIMITED, ILLUMINA SINGAPORE PTE. LTD.Inventors: Wayne N. GEORGE, Jonathan Mark BOUTELL, Mathieu LESSARD-VIGER, Saurabh NIRANTAR, Pietro GATTI LAFRANCONI, Seth MCDONALD, Yin Nah TEO, Maria Rogert BACIGALUPO, Sergio PEISAJOVICH, Eric BRUSTAD, Michael HOWARD, Xiangyuan YANG, M. Shane Bowen, Alex NEMIROSKI, Jeffrey BRODIN, Ludovic VINCENT, Lorenzo BERTI, Andrew A. BROWN, Fei SHEN, Lena STORMS, Olivia BENICE
-
Publication number: 20090181858Abstract: Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal leucyl-tRNAs, orthogonal leucyl-aminoacyl-tRNA synthetases, and orthogonal pairs of leucyl-tRNAs/synthetases, which incorporate photoregulated amino acids, OMe-L-tyrosine, ?-aminocaprylic acid, or o-nitrobenzyl cysteine into proteins are proteins are provided in response to an amber selector codon. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins with a photoregulated amino acid, Ome-L-tyrosine, ?-aminocaprylic acid, or o-nitrobenzyl cysteine using these orthogonal pairs.Type: ApplicationFiled: September 21, 2005Publication date: July 16, 2009Applicant: The Scripps Research InstituteInventors: Alexander Deiters, Ning Wu, Peter G. Schultz, David King, T. Ashton Cropp, Mohua Bose, Dan Groff, Jianming Xie, Eric Brustad
-
Publication number: 20090148887Abstract: Provided are compositions comprising an aminoacyl tRNA synthetase that selectively recognizes a boronic amino acid. Methods of incorporating a boronic amino acid into a target polypeptides and target polypeptides produced by the methods are also provided. Methods of producing a protein, which methods comprise site-specifically encoding a boronic amino acid residue into a mutant protein and selectively converting the boronic amino acid residue into a natural amino acid residue are provided. Also provided are compositions comprising a solid phase matrix covalently bound to a polypeptide through a boronic amino acid residue. In addition, compositions comprising a purified population of polypeptide molecules that each comprise a borono amino acid at a selected site are provided.Type: ApplicationFiled: October 30, 2008Publication date: June 11, 2009Applicant: THE SCRIPPS RESEARCH INSTITUTEInventors: ERIC BRUSTAD, MARK L. BUSHEY, PETER G. SCHULTZ
-
Publication number: 20060134746Abstract: Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal leucyl-tRNAs, orthogonal leucyl-aminoacyl-tRNA synthetases, and orthogonal pairs of leucyl-tRNAs/synthetases, which incorporate photoregulated amino acids, OMe-L-tyrosine, ?-aminocaprylic acid, or o-nitrobenzyl cysteine into proteins are provided in response to an amber selector codon. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins with a photoregulated amino acid, OMe-L-tyrosine, ?-aminocaprylic acid, or o-nitrobenzyl cysteine using these orthogonal pairs.Type: ApplicationFiled: September 21, 2005Publication date: June 22, 2006Applicant: The Scripps Research InstituteInventors: Alexander Deiters, Ning Wu, Peter Schultz, David King, T. Cropp, Mohua Bose, Dan Groff, Jianming Xie, Eric Brustad